Spero Therapeutics, Inc. ( SPRO) - Key Metrics
SPRO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2025Q1 | $0.11 | ? | -$0.07 | -$0.07 |
SPRO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | ? |
SPRO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 11.84% | ? |
| 2025Q4 | -6.40% | ? |
| 2025Q3 | 16.47% | ? |
| 2025Q2 | -10.89% | ? |
| 2025Q1 | -10.04% | ? |
SPRO
Price: $2.77
52 week price:
Earnings Per Share: 0.27 USD
P/E Ratio: 9.63
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 179389
Market Capitalization: 163.3 million